Friday, July 10, 2026

pharma · Osteoarthritis · Osteoporosis

Nordic Bioscience

Nordic Bioscience clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Herlev, DK HQ
1991 Founded
228 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Herlev, DK
Founded
1991
Employees
228
Programs
5
Drugs
10
Patents
0
Intelligence · Clinical Programs

Nordic Bioscience projects

2 ClinicalTrials.gov programs sponsored by Nordic Bioscience.

Nordic Bioscience has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. SMC021 Oral Calcitonin

    Nordic Bioscience A/S

    Osteoarthritis

    phase 3 small molecule completed

    1 trial
  2. SMC021 Oral calcitonin

    Nordic Bioscience A/S

    Osteoporosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Nordic Bioscience have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.